# A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

> **NCT04572698** · PHASE3 · UNKNOWN · sponsor: **Luye Pharma Group Ltd.** · enrollment: 416 (estimated)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** LY09004
- **DRUG:** Eylea

## Key facts

- **NCT ID:** NCT04572698
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11
- **Primary completion:** 2023-06
- **Final completion:** 2023-12
- **Target enrollment:** 416 (ESTIMATED)
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04572698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04572698, "A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04572698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*